FDA NDC Directory · JSON-LD · Markdown

VESIcare LS

NDC 51248-250 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic namesolifenacin succinate
Labeler / ManufacturerAstellas Pharma US, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA209529
Dosage form / routeSUSPENSION · ORAL
Active ingredientsSOLIFENACIN SUCCINATE (1 mg/mL)
Marketing started20200526
Marketing ended20260731
Package count1

External sources

Source: openFDA. Public-domain (CC0).